ERBB3 and triple-negative breast carcinoma: A similar effect of perhexiline on decreasing HER3 expression was detected in triple-negative breast cancer MDA-MB-468 cells that express EGFR and HER3, but not HER2 (Figure S2 A-D in Additional file 2).